NCT04189731

Brief Summary

Shoulder surgery is performed usually under interscalene block considered as a gold standard. This anesthesia is well suited for hospitalized patients but not for outpatients. The Orthopedic Surgery Department of Clinique Chénieux has been operating patients requiring arthroscopic shoulder surgery with a short interscalene block relayed by a long suprascapular block. The main objective is to evaluate the effectiveness of this method by measuring the average pain over 3 days after the operation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 2, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 6, 2019

Completed
11 months until next milestone

Study Start

First participant enrolled

November 5, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 27, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 27, 2021

Completed
Last Updated

January 24, 2022

Status Verified

January 1, 2022

Enrollment Period

11 months

First QC Date

December 2, 2019

Last Update Submit

January 6, 2022

Conditions

Keywords

Shoulder surgerypainsuprascapular block

Outcome Measures

Primary Outcomes (3)

  • Average of pain

    Score of average pain at D1, D2 and D3 by a numeric pain scale (NPS) \<4/10

    Day1

  • Average of pain

    core of average pain at D2 by a numeric pain scale (NPS) \<4/10

    Day2

  • Average of pain

    core of average pain at D3 by a numeric pain scale (NPS) \<4/10

    Day 3

Secondary Outcomes (7)

  • Number of readmissions

    Day 7

  • Number of painful peaks

    Day 0

  • Analgesics consummation

    Day 1, Day 2, Day 3, Day 4 and Day 7

  • Score of Pain

    Day 4, Day 7, Day 15 and Day 30

  • Satisfied patient rate

    Day 30

  • +2 more secondary outcomes

Study Arms (1)

supra-scapular block

Patient will have a short ISB (between 2h and 4h) relayed by a supra-scapular block (SSB) long (72h) through the placement of a perineural catheter thus allowing a continuous diffusion of Naropein® by an elastomeric pump

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient in need of acromioplasty or rotator cuff surgery (ruptured cuff or calcification of the cuff) or reinsertion of the glenoid bead (Bankart intervention)

You may qualify if:

  • Men, women between 18 and 70 years
  • Patient in need of acromioplasty or rotator cuff surgery (ruptured cuff or calcification of the cuff) or reinsertion of the glenoid bead (Bankart intervention)
  • Patient with an American Society of Anesthesiologists score (ASA) of 1 or 2

You may not qualify if:

  • Patient needing shoulder surgery for other indications and open surgery
  • Patient with cognitive impairment or dementia symptoms
  • Patient with a BMI ≥ 35 without systemic morbidity requiring hospitalization
  • Contraindication to the drugs used in the study (hypersensitivity to ropivacaine or other amide-bonded local anesthetics)
  • Pregnant or lactating patient
  • Patient with severe hepatic impairment
  • Class III antiarrhythmic patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Chénieux

Limoges, France

Location

MeSH Terms

Conditions

Shoulder PainPain

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2019

First Posted

December 6, 2019

Study Start

November 5, 2020

Primary Completion

September 27, 2021

Study Completion

September 27, 2021

Last Updated

January 24, 2022

Record last verified: 2022-01

Locations